SEARCH

SEARCH BY CITATION

References

  • 1
    Ahmann, D. L., Bisel, H. F., Eagan, R. T., Edmonson, J. H., and Hahn, R. G.: Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer. Cancer Chemother. Rep. 58 (Part I): 877882, 1974.
  • 2
    Ahmann, D. L., Bisel, H. F., and Hahn, R. G.: Phase II clinical trial of isophosphamide (NSC-109724) in patients with advanced breast cancer. Cancer Chemother. Rep. 58 (Part I): 861865, 1974.
  • 3
    Ahmann, D. L., Bisel, H. F., and Hahn, R. G.: A phase II evaluation of 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (methyl-CCNU, NSC-95441) in patients with advanced breast cancer. Cancer Res. 34: 2730, 1974.
  • 4
    Ansfield, F. J., Ramirez, G., Mackman, S., Bryan, G. T., and Curreri, A. R.: A ten-year study of 5-fluorouracil in disseminated breast cancer with clinical results and survival times. Cancer Res. 29: 10621066, 1969.
  • 5
    Carter, S. K.: Single and combination nonhor-monal chemotherapy in breast cancer. Cancer 30: 15431555, 1972.
  • 6
    Colsky, J., Shnider, B., Jones, R., Jr., Nevinny-Stickel, H. B., Hall, T., Regelson, W., Selawry, O. S., Owens, A., Jr., Brindley, C. O., Frei, E., III, and Uzer, Y.: A comparative study of 9α-bromo-11β-ketoprogesterone and prednisolone in the treatment of advanced carcinoma of the female breast. Cancer 16: 502505, 1963.
  • 7
    Cooper, R. G.: Combination chemotherapy in hormone resistant breast cancer. Proc. Am. Assoc. Cancer, 10: 15, 1969. (Abstract)
  • 8
    Cooperative Breast Cancer Group: Results of studies of the cooperative breast cancer group—1961–1963. Cancer Chemother. Rep. 41 (Suppl 1): 124, 1964.
  • 9
    DeVita, V. T., Jr., Serpick, A. A., and Carbone, P. P.: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann. Intern. Med. 73: 881895, 1970.
  • 10
    Frei, E., III, and Freireich, E. J.: Progress and perspectives in the chemotherapy of acute leukemia. Adv. Chemother. 2: 269298, 1965.
  • 11
    Gailani, S.: Phase II studies of vincristine (VCR) in human cancer. Proc. Am. Assoc. Cancer Res. 51–54: 21, 1960–1963. (Abstract)
  • 12
    Greenspan, E. M.: Combination cytotoxic chemotherapy in advanced disseminated breast cancer. Mt. Sinai J. Med. N.Y. 33: 127, 1966.
  • 13
    Lemon, H. M.: Prednisone therapy of advanced mammary cancer. Cancer 12: 93107, 1959.
  • 14
    Livingston, R. B., and Carter, S. K.: Single Agents in Cancer Chemotherapy. New York, IFI/ Plenum, 1970.
  • 15
    Tally, R. W., Vaitkevicius, V. K., and Leighton, G. A.: Comparison of cyclophosphamide and 5-fluorouracil in the treatment of patients with metastatic breast cancer. Clin. Pharmacol. Ther. 6: 740748, 1965.
  • 16
    Zelen, M.: Keynote address on biostatistics and data retrieval. Cancer Chemother. Rep. 4 (Suppl. 4): 3142, 1973.